Cargando…
P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430559/ http://dx.doi.org/10.1097/01.HS9.0000846440.48761.8d |
| _version_ | 1784779805431955456 |
|---|---|
| author | Bobin, A. Manier, S. De Keizer, J. Karlin, L. Perrot, A. Hulin, C. Caillot, D. Mariette, C. Lenain, P. Richez, V. Tiab, M. Touzeau, C. Jaccard, A. Decaux, O. Araujo, C. Belhadj, K. Benboubker, L. Déal, C. Macro, M. Vincent, L. Arnulf, B. Bareau, B. Braun, T. Calmettes, C. mamoun, D. Zerazhi, H. Demarquette, H. Feugier, P. Fohrer-sonntag, C. Godet, S. Petillon, M.-O. Avet-Loiseau, H. Leleu, X. |
| author_facet | Bobin, A. Manier, S. De Keizer, J. Karlin, L. Perrot, A. Hulin, C. Caillot, D. Mariette, C. Lenain, P. Richez, V. Tiab, M. Touzeau, C. Jaccard, A. Decaux, O. Araujo, C. Belhadj, K. Benboubker, L. Déal, C. Macro, M. Vincent, L. Arnulf, B. Bareau, B. Braun, T. Calmettes, C. mamoun, D. Zerazhi, H. Demarquette, H. Feugier, P. Fohrer-sonntag, C. Godet, S. Petillon, M.-O. Avet-Loiseau, H. Leleu, X. |
| author_sort | Bobin, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430559 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94305592022-08-31 P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01 Bobin, A. Manier, S. De Keizer, J. Karlin, L. Perrot, A. Hulin, C. Caillot, D. Mariette, C. Lenain, P. Richez, V. Tiab, M. Touzeau, C. Jaccard, A. Decaux, O. Araujo, C. Belhadj, K. Benboubker, L. Déal, C. Macro, M. Vincent, L. Arnulf, B. Bareau, B. Braun, T. Calmettes, C. mamoun, D. Zerazhi, H. Demarquette, H. Feugier, P. Fohrer-sonntag, C. Godet, S. Petillon, M.-O. Avet-Loiseau, H. Leleu, X. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430559/ http://dx.doi.org/10.1097/01.HS9.0000846440.48761.8d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Bobin, A. Manier, S. De Keizer, J. Karlin, L. Perrot, A. Hulin, C. Caillot, D. Mariette, C. Lenain, P. Richez, V. Tiab, M. Touzeau, C. Jaccard, A. Decaux, O. Araujo, C. Belhadj, K. Benboubker, L. Déal, C. Macro, M. Vincent, L. Arnulf, B. Bareau, B. Braun, T. Calmettes, C. mamoun, D. Zerazhi, H. Demarquette, H. Feugier, P. Fohrer-sonntag, C. Godet, S. Petillon, M.-O. Avet-Loiseau, H. Leleu, X. P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01 |
| title | P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01 |
| title_full | P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01 |
| title_fullStr | P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01 |
| title_full_unstemmed | P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01 |
| title_short | P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01 |
| title_sort | p891: ixazomib, pomalidomide and dexamethasone (ixpd) in relapsed or refractory multiple myeloma (rrmm) characterized with high-risk cytogenetics. ifm 2014-01 |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430559/ http://dx.doi.org/10.1097/01.HS9.0000846440.48761.8d |
| work_keys_str_mv | AT bobina p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT maniers p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT dekeizerj p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT karlinl p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT perrota p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT hulinc p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT caillotd p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT mariettec p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT lenainp p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT richezv p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT tiabm p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT touzeauc p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT jaccarda p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT decauxo p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT araujoc p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT belhadjk p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT benboubkerl p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT dealc p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT macrom p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT vincentl p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT arnulfb p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT bareaub p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT braunt p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT calmettesc p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT mamound p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT zerazhih p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT demarquetteh p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT feugierp p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT fohrersonntagc p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT godets p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT petillonmo p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT avetloiseauh p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 AT leleux p891ixazomibpomalidomideanddexamethasoneixpdinrelapsedorrefractorymultiplemyelomarrmmcharacterizedwithhighriskcytogeneticsifm201401 |